🇺🇸 FDA

Intelligence · Patent portfolio

Regeneron Ireland Designated Patents

Full USPTO pharma patent portfolio for Regeneron Ireland Designated — grant dates, expiration, and drug cross-links.

Patents
8,292
Expiring ≤24m
426

Quick answer

Regeneron Ireland Designated has 8,292 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 426 expire within 24 months — use filters for patent-cliff planning.

Page 146 of 173

  1. US 6979730

    Nucleic acids encoding prostate stem cell antigen

    Expires Mon Dec 22 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  2. US 6979702

    Ionomer composite compositions

    Expires Mon Dec 22 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  3. US 6979677

    Inhibition of vascular smooth muscle cell proliferation

    Expires Mon Dec 22 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  4. US 6979451

    Recombinant antigen MSP1a from anaplasma marginale to reduce infections in ticks, vaccine compositions and methods of use

    Expires Mon Dec 22 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  5. US 6977079

    Avian pneumovirus vaccine

    Expires Mon Dec 15 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  6. US 6977244

    Inhibition of Bcl-2 protein expression by liposomal antisense oligodeoxynucleotides

    Expires Mon Dec 15 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  7. US 6974568

    Treatment for cough

    Expires Mon Dec 08 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  8. US 6974580

    Mycobacterial sulfation pathway proteins and methods of use thereof

    Expires Mon Dec 08 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  9. US 6974593

    Insoluble drug delivery

    Expires Mon Dec 08 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  10. US 6969480

    Method of producing structures using centrifugal forces

    Expires Mon Nov 24 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  11. US 6967019

    Production of pancreatic islet cells and delivery of insulin

    Expires Mon Nov 17 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  12. US 6967240

    Congener independent detection of microcystin and nodularin congeners

    Expires Mon Nov 17 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  13. US 6967093

    Glycosyl sulfotransferase-3

    Expires Mon Nov 17 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  14. US 6962716

    Compositions and methods for biodegradable microspheres as carriers of bioactive substances

    Expires Mon Nov 03 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  15. US 6962798

    Methods and compositions relating to a cardiac-specific nuclear regulatory factor

    Expires Mon Nov 03 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  16. US 6960652

    Compositions and methods for modifying toxic effects of proteinaceous compounds

    Expires Mon Oct 27 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  17. US 6960443

    Methods of detecting prostate stem cell antigen in cancer

    Expires Mon Oct 27 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  18. US 6958321

    Isolation, characterization, cloning and use of a mushroom lectin

    Expires Mon Oct 20 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  19. US 6958238

    Isolated dishevelled associated kinases, polynucleotides encoding the kinases, and methods of use thereof

    Expires Mon Oct 20 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  20. US 6958151

    Miniprotein ligands and other polypeptides and methods for making and using same

    Expires Mon Oct 20 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  21. US 6958345

    2-hydroxymethylcyclopropylidene methylpurines and -pyrimidines as antiviral agents

    Expires Mon Oct 20 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  22. US 6955894

    Method for producing TNF receptor releasing enzyme

    Expires Mon Oct 13 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  23. US 6956145

    Mice models of human prostate cancer progression

    Expires Mon Oct 13 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  24. US 6953834

    Transcription factors related to TFIIA

    Expires Mon Oct 06 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  25. US 6953575

    Methods of treating central nervous system disorders using viral vectors

    Expires Mon Oct 06 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  26. US 6953779

    Melanocortin receptor antagonists and modulations of melanocortin receptor activity

    Expires Mon Oct 06 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  27. US 6953786

    Compositions comprising plant-derived polyphenolic compounds and inhibitors of reactive oxygen species and methods of using thereof

    Expires Mon Oct 06 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  28. US 6951847

    Methods of treating fungal infections using lupeol

    Expires Mon Sep 29 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  29. US 6951735

    Death domain containing receptors

    Expires Mon Sep 29 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  30. US 6951653

    Streptococcal C5a peptidase vaccine

    Expires Mon Sep 29 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  31. US 6951845

    Method for treating allergic lung disease

    Expires Mon Sep 29 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  32. US 6951743

    Hyaluronan synthase genes and expression thereof in bacillus hosts

    Expires Mon Sep 29 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  33. US 6949647

    Synthesis of pancratistatin

    Expires Mon Sep 22 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  34. US 6949255

    Inhibitory chemical formulation with preservative system

    Expires Mon Sep 22 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  35. US 6949690

    Methods of assessing the effect of a gene of interest on human prostate cancer progression

    Expires Mon Sep 22 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  36. US 6946441

    Inhibition of histone deacetylase as a treatment for cardiac hypertrophy

    Expires Mon Sep 15 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  37. US 6946132

    Vaccine compositions and methods useful in inducing immune protection against arthritogenic peptides involved in the pathogenesis of rheumatoid arthritis

    Expires Mon Sep 15 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  38. US 6943153

    Use of recombinant gene delivery vectors for treating or preventing diseases of the eye

    Expires Mon Sep 08 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  39. US 6942663

    Laser treatment of cutaneous vascular lesions

    Expires Mon Sep 08 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  40. US 6943194

    Synthesis of phenstatin and prodrugs thereof

    Expires Mon Sep 08 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  41. US 6942870

    Compositions and methods using direct MMP inhibitors for inhibiting photoaging of skin

    Expires Mon Sep 08 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  42. US 6942855

    Viral vectors having reduced virulence

    Expires Mon Sep 08 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  43. US 6942879

    Bioartificial filtration device for filtering blood to mimic kidney function

    Expires Mon Sep 08 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  44. US 6943027

    Preparation of stable formulations of lipid-nucleic acid complexes for efficient in vivo delivery

    Expires Mon Sep 08 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  45. US 6943245

    Tumor suppressor CAR-1

    Expires Mon Sep 08 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  46. US 6939945

    Synthetic peptides, conjugation reagents and methods

    Expires Mon Sep 01 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  47. US 6939847

    Use of colostrinin, constituent peptides thereof, and analogs thereof, as oxidative stress regulators

    Expires Mon Sep 01 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  48. US 6939549

    Immunoprotective recombinant antigen from anaplasma marginale, vaccine compositions and methods of use

    Expires Mon Sep 01 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

Frequently asked questions

How many patents does Regeneron Ireland Designated have?

8,292 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Regeneron Ireland Designated patents expire?

426 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources · Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.